Glaucoma surgery can reverse cupping

Article

Significantly more glaucoma patients, who are treated surgically rather than medically, will experience reversal of cupping.

Significantly more glaucoma patients, who are treated surgically rather than medically, will experience reversal of cupping, according to a study presented at the Pan-American Association of Ophthalmology congress in Cancun, Mexico.

Richard Parish, MD presented five-year data analysis from the Collaborative Initial Glaucoma Treatment Study (CIGTS). Investigators initially obtained optic disc photos from 607 patients with open angle glaucoma. Of these, 346 had follow-up photos of adequate quality, at the five-year mark, to be considered for analysis.

A total of 61 eyes were considered to have undergone changes of the optic disc and were sent to the CIGTS Optic Disc Endpoint Committee, which agreed on 45 of the 61 readings. They were surprised to discover that 25 of the eyes showed a reversal in optic disc cupping rather than the expected progression. The investigators found that 14% of patients treated surgically had undergone a reversal of cupping, compared with just 1% of those treated medically.

It was concluded that glaucoma surgery can, in some cases, reverse optic disc cupping.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.